These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 34136953)

  • 1. An Appraisal of Bacteriophage Isolation Techniques from Environment.
    Nair A; Ghugare GS; Khairnar K
    Microb Ecol; 2022 Apr; 83(3):519-535. PubMed ID: 34136953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages in nature: recent advances in research tools and diverse environmental and biotechnological applications.
    Bisen M; Kharga K; Mehta S; Jabi N; Kumar L
    Environ Sci Pollut Res Int; 2024 Mar; 31(15):22199-22242. PubMed ID: 38411907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.
    Azam AH; Tanji Y
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2121-2131. PubMed ID: 30680434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Two-step, High Yield Protocol for Isolation and Amplification of Bacteriophages Against Methicillin-resistant Staphylococcus Aureus (MRSA).
    Khan A; Joshi H
    Curr Protoc; 2022 Mar; 2(3):e395. PubMed ID: 35259286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages: from Isolation to Application.
    Abdelsattar A; Dawoud A; Makky S; Nofal R; Aziz RK; El-Shibiny A
    Curr Pharm Biotechnol; 2022; 23(3):337-360. PubMed ID: 33902418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Bacteriophages for Practical Applications.
    Pizarro-Bauerle J; Ando H
    Biol Pharm Bull; 2020; 43(2):240-249. PubMed ID: 32009112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Bacteriophage Therapy in Field Conditions and Possible Future Applications.
    Adhikari N; Acharya KP
    Curr Pharm Biotechnol; 2020; 21(5):364-373. PubMed ID: 31845630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic Pathogens.
    Peters DL; Harris G; Davis CM; Dennis JJ; Chen W
    Curr Protoc; 2022 Nov; 2(11):e594. PubMed ID: 36383057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy: recent developments and applications of a renaissant weapon.
    Fathima B; Archer AC
    Res Microbiol; 2021; 172(6):103863. PubMed ID: 34293451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified bacteriophages.
    Sagona AP; Grigonyte AM; MacDonald PR; Jaramillo A
    Integr Biol (Camb); 2016 Apr; 8(4):465-74. PubMed ID: 26906932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and clinical importance of bacteriophage resistance.
    Egido JE; Costa AR; Aparicio-Maldonado C; Haas PJ; Brouns SJJ
    FEMS Microbiol Rev; 2022 Feb; 46(1):. PubMed ID: 34558600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
    Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
    Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary biology and development model of medicines: A necessary 'pas de deux' for future successful bacteriophage therapy.
    Froissart R; Brives C
    J Evol Biol; 2021 Dec; 34(12):1855-1866. PubMed ID: 34288190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing of bacteriophages for therapeutic applications.
    João J; Lampreia J; Prazeres DMF; Azevedo AM
    Biotechnol Adv; 2021; 49():107758. PubMed ID: 33895333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of bacteriophage therapy for pathogenic bacteria inactivation in the soil environment.
    Ye M; Sun M; Huang D; Zhang Z; Zhang H; Zhang S; Hu F; Jiang X; Jiao W
    Environ Int; 2019 Aug; 129():488-496. PubMed ID: 31158595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.